Norway Mrna Therapeutics Contract Development & Manufacturing Market Size & Outlook
Related Markets
Norway mrna therapeutics contract development & manufacturing market highlights
- The Norway mrna therapeutics contract development & manufacturing market generated a revenue of USD 21.4 million in 2024 and is expected to reach USD 75.5 million by 2033.
- The Norway market is expected to grow at a CAGR of 15.9% from 2025 to 2033.
- In terms of segment, infectious diseases was the largest revenue generating indication in 2024.
- Metabolic & Genetic Diseases is the most lucrative indication segment registering the fastest growth during the forecast period.
Mrna therapeutics contract development & manufacturing market data book summary
| Market revenue in 2024 | USD 21.4 million |
| Market revenue in 2033 | USD 75.5 million |
| Growth rate | 15.9% (CAGR from 2025 to 2033) |
| Largest segment | Infectious diseases |
| Fastest growing segment | Metabolic & Genetic Diseases |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Metabolic & Genetic Diseases, Cardiovascular & Cerebrovascular Diseases, Infectious Diseases |
| Key market players worldwide | Danaher Corp, Kaneka Corp, TriLink BioTechnologies, Apex Biotechnology, BioNTech SE ADR, Lonza Group Ltd, Nunn’s Home Medical Equipment, EQT Corp, Catalent Inc, Samsung Electronics Co Ltd, Biomay AG, Indication, eTheRNA immunotherapies, BioCina |
Other key industry trends
- In terms of revenue, Norway accounted for 0.5% of the global mrna therapeutics contract development & manufacturing market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Europe, Germany mrna therapeutics contract development & manufacturing market is projected to lead the regional market in terms of revenue in 2033.
- Sweden is the fastest growing regional market in Europe and is projected to reach USD 213.5 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
MRNA Therapeutics Contract Development & Manufacturing Market Scope
MRNA Therapeutics Contract Development & Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| BioCina | View profile | 101-250 | Thebarton, South Australia, Australia, Oceania | https://www.biocina.com/ |
| eTheRNA immunotherapies | View profile | 51-100 | Jette, Brussels Hoofdstedelijk Gewest, Belgium, Europe | http://www.etherna.be/ |
| Indication | View profile | 1-10 | Sandhausen, Baden-Wurttemberg, Germany, Europe | http://www.indication.com |
| Biomay AG | View profile | - | Vienna, Wien, Austria, Europe | https://www.biomay.com/ |
| BioNTech SE ADR | View profile | 6133 | An der Goldgrube 12, Mainz, RP, Germany, D-55131 | https://www.biontech.de |
| Kaneka Corp | View profile | 13284 | 3-2-4, Nakanoshima, Kita-ku, Osaka, Japan, 530-8288 | http://www.kaneka.co.jp |
| TriLink BioTechnologies | View profile | 251-500 | San Diego, California, United States, North America | http://www.trilinkbiotech.com/ |
| EQT Corp | View profile | 881 | 625 Liberty Avenue, Suite 1700, Pittsburgh, PA, United States, 15222 | https://www.eqt.com |
| Catalent Inc | View profile | 17219 | 14 Schoolhouse Road, Somerset, NJ, United States, 08873 | https://www.catalent.com |
| Apex Biotechnology | View profile | - | Hsinchu, T'ai-wan, Taiwan, Asia | http://www.apexbio.com |
| Nunn’s Home Medical Equipment | View profile | 101-250 | Rome, New York, United States, North America | https://www.nunnshme.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Samsung Electronics Co Ltd | View profile | 124804 | 129, Samsung-ro, Yeongtong-gu, Gyeonggi-do, Suwon-si, Korea, Republic of, 443-742 | https://www.samsung.com |
| Lonza Group Ltd | View profile | 18000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | https://www.lonza.com |
Norway mrna therapeutics contract development & manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mrna therapeutics contract development & manufacturing market will help companies and investors design strategic landscapes.
Infectious diseases was the largest segment with a revenue share of 72.43% in 2024. Horizon Databook has segmented the Norway mrna therapeutics contract development & manufacturing market based on metabolic & genetic diseases, cardiovascular & cerebrovascular diseases, infectious diseases covering the revenue growth of each sub-segment from 2021 to 2033.
Key players involved in the development of mRNA therapeutics are expanding their commercial networks to support the delivery of mRNA vaccines and therapeutics locally, which is expected to create growth opportunities for mRNA therapeutics CDMO players to support the manufacturing of mRNA-based therapeutics.
The Norwegian Medicines Agency (NoMA) is a national regulatory authority that oversees the trials, supply chain, and manufacturing of both existing and new medicines & drugs in Norway. Before being marketed in Norway, a medicine must first receive marketing authorization from NoMA.
Reasons to subscribe to Norway mrna therapeutics contract development & manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Norway mrna therapeutics contract development & manufacturing market databook
-
Our clientele includes a mix of mrna therapeutics contract development & manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway mrna therapeutics contract development & manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Norway mrna therapeutics contract development & manufacturing market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Norway mrna therapeutics contract development & manufacturing market size, by indication, 2021-2033 (US$M)
Norway MRNA Therapeutics Contract Development & Manufacturing Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
